Filing Flows

Filing Flows › Tela Bio (TELA) › Next earnings date

Tela Bio (TELA) earnings on Nov 10, 2026: what to expect

Tela Bio (TELA) is expected to report earnings on Nov 10, 2026, in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.16 (−$0.21 to −$0.13, 5 estimates) on revenue of $20.0M, against −$0.19 and $20.7M a year ago. It beat the EPS estimate in 67% of the quarters on record; Filing Flows' model gives it a 72% chance of beating next time.

Report dateNov 10, 2026
Days to go2
EPS estimate−$0.16
Revenue estimate$20.0M
Beat rate67%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

Tela Bio: revenue lines, growth year over year, Q2 2026Tela Bio: revenue lines, growth year over year, Q2 2026Revenue-4%

Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.19 on revenue of $21.0M, against the analysts' −$0.16.

The last report

Tela Bio reported revenue of $19.3M for the second quarter 2026 (-4% Y/Y), net loss $11.3M. How it makes money → · Every quarter →

Tela Bio: EPS against the estimate, last 3 reportsTela Bio: EPS against the estimate, last 3 reportsEstimateReported−$0.20−$0.19Nov 25−$0.18−$0.17Mar 26−$0.18−$0.20Aug 26
Latest (Aug 26): Estimate −$0.18, Reported −$0.20.

Tela Bio's latest quarter

Tela Bio, Q2 2026: revenue $19.3M (-4% year over year), operating margin -48.1%, net loss $11.3M, operating cash flow −$9.4M. The chart follows the revenue to costs, profit and cash.

Questions

When does TELA report earnings?

Tela Bio is expected to report on Nov 10, 2026.

What are analysts expecting from Tela Bio?

EPS of −$0.16 and revenue of $20.0M for the quarter.

Does Tela Bio usually beat earnings?

It beat the consensus EPS estimate in 67% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.